Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Human Microbiome Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. According to this research, the global…
DUBLIN–(BUSINESS WIRE)–The “Biosimilars Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering. In…
The FDA has granted first approvals for the generic versions of Lyrica to Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr. Reddy’s Laboratories, InvaGen Pharmaceuticals, MSN Laboratories Ltd., Rising Pharmaceuticals, Inc., Sciegen Pharmaceuticals Inc., and Teva Pharmaceuticals.
Week 96 data from the BRIGHTE study of first-in-class fostemsavir continue to show improvement in virologic suppression and immunologic response…
Yellow Wood Partners will buy the Dr. Scholl’s foot care business from Bayer for a purchase price of $585 million, the companies said amid Bayer’s voluntarily recall of a product in the USA.
Bayer is voluntarily recalling two lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU vials in the United States to the patient level, the company said Monday in a statement.
DUBLIN–(BUSINESS WIRE)–The “Novel Immuno-Oncology Biomarker Testing Market, 2019-2030” report has been added to ResearchAndMarkets.com’s offering. This report features an extensive…
DUBLIN–(BUSINESS WIRE)–The “INCB050465” report has been added to ResearchAndMarkets.com’s offering. INCB050465 (Incyte) is an oral phosphoinositide 3-kinase (PI3K) delta-specific inhibitor.…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Plastic Bottles Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service),…